Skip to main content

Robert Lew, MD

08/01/2008
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Vascular brachytherapy (VBT) has evolved as a viable method to treat in-stent restenosis (ISR), which is due to neointimal hyperplasia distributed either focally or diffusely over the entire length of the stent.1 Radiation acts by inhibiting...
Vascular brachytherapy (VBT) has evolved as a viable method to treat in-stent restenosis (ISR), which is due to neointimal hyperplasia distributed either focally or diffusely over the entire length of the stent.1 Radiation acts by inhibiting...
Vascular brachytherapy (VBT) has...
08/01/2008
Journal of Invasive Cardiology